Articles tagged with 'Consumer Health' | Bayer

Basel, Switzerland, March 7, 2023 — A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software...

Group sales increase 8.7 percent (Fx & portfolio adj.) to 50.739 billion euros / EBITDA before special items rises 20.9 percent to 13.513 billion euros, largely driven by exceptionally strong performance at Crop Science / Pharmaceuticals increases sa...

The Nutrient Gap Initiative, aiming to improve access to essential nutrients for 50 million people by 2030, expands its scope to include both supplementation and food

Chairman of the Board of Management / Chief Financial Officer

Empowering consumers to take more control over their own health means ensuring they have the knowledge and trust that products are safe and will work as described  / The Principles of Science-Led Self-Care paper forms a blueprint for the industry...

Group sales grow by 14.3 percent (Fx & portfolio adj.) to 14.639 billion euros / EBITDA before special items increases by 27.5 percent to 5.251 billion euros / Substantial sales and earnings growth at Crop Science and Consumer Health / Sales up sligh...

Chairman of the Board of Management

Chairman of the Supervisory Board of Bayer AG

Werner Baumann, Chairman of the Board of Management (CEO) of Bayer AG:Good morning everybody! On behalf of the entire Board of Management, I would like to wish you all a very warm welcome to our virtual Financial News Conference. I am delighted that ...

Group sales increase by 8.9 percent (Fx & portfolio adj.) to 44.081 billion euros / EBITDA before special items declines by 2.5 percent to 11.179 billion euros - inflation-related increase in costs and negative currency effects largely offset / Crop ...

Basel, Switzerland, February 2, 2022 - Today Bayer announced Dr. Ricardo Salazar Hernández as the new Global Medical Affairs function with responsibilities over medical insights, claims and evidence strategies and generation, and health care professi...

The Consumer Health division accelerates the execution of its sustainability program and strikes partnership for collective action across the self care industry

Chairman of the Board of Management / Chief Financial Officer

Group sales rise by 14.3 percent (Fx & portfolio adj.) to 9.781 billion euros / EBITDA before special items increases by 16.4 percent to 2.089 billion euros / Crop Science reports strong increase in sales and earnings / Pharmaceuticals and Consumer H...

Group sales increase by 12.9 percent (Fx & portfolio adj.) to 10.854 billion euros - double-digit percentage growth (Fx & portfolio adj.) at all divisions / EBITDA before special items declines by 10.6 percent to 2.577 billion euros, burdened by curr...

Ada Health combines medical knowledge with powerful AI to revolutionize possibilities for personal health for patients globally / Investment to support advancement of Ada’s symptom assessment and care navigation platform...

Good operational performance - sales and earnings negatively impacted by currency of 938 million euros and 337 million euros / Group sales up by 2.8 percent (Fx & portfolio adj.) to 12.328 billion euros / EBITDA before special items down 6.2 percent ...

Stable operational development in fiscal 2020 despite the COVID-19 pandemic / Dividend of 2.00 euros per share proposed / Early indications of a successful start to 2021 / Board of Management regards Bayer as better positioned than almost any other c...

Chairman of the Supervisory Board of Bayer AG

Chairman of the Board of Management

Chairman of the Board of Management / Chief Financial Officer

Group sales at 41.400 billion euros, impacted by negative currency effects of 1.941 billion euros (Fx & portfolio adj. plus 0.6 percent) / EBITDA before special items level with prior year at 11.461 billion euros (minus 0.1 percent) - currency effect...

Primary Focus will be on Most Vulnerable - Pregnant Women and Children in Underserved Communities

Deal deepens Bayer’s capabilities in the personalized healthcare and nutritionals space

Chairman of the Board of Management / Chief Financial Officer

Group sales decrease by 5.1 percent (Fx & portfolio adj.) to 8.506 billion euros / EBITDA before special items falls 21.4 percent to 1.795 billion euros / Substantial decline in sales and earnings at Crop Science, heavily impacted by seasonal and cur...

Senior Marketing Leaders from top creative agencies and world-renowned brands volunteering to work with Bayer to enhance creativity and inspire consumers to take better care of their health

Bayer launches Mission 1000+ campaign to empower parents with knowledge about the role of nutrition in their baby’s development

Harnessing the human skin microbiome to develop cutting-edge solutions moving the paradigm from treatment to cure in dermatology / Investment to support advancement of Azitra’s technology platform for both clinical and consumer programs...

Ensuring employee safety and maintaining supply chains remain top priorities / Group sales decline by 2.5 percent (Fx & portfolio adj.) to 10.054 billion euros / EBITDA before special items up 5.6 percent to 2.883 billion euros / Crop Science reports...